Endothelial Cell Specific Molecule-1 (ESM-1): a Novel Biomarker for ARDS Endothelial Injury

Clinical trial NCT03296761 · UNKNOWN

Trial details

NCT number: NCT03296761
Sponsor: Jingyuan,Xu
Status: UNKNOWN
Study type: OBSERVATIONAL

Evaluate the Correlation Between the Level of ESM-1 and the Prognosis of the Patients With ARDS

Start date: 2017-11-01
Primary completion: 2017-12-20
Enrollment: 70

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.